Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

about

Clinical profile of contraceptive progestins Contraceptive applications of progesterone receptor modulators.Gynaecological uses of a new class of steroids: the selective progesterone receptor modulators.

P2860

Q28306370-2511074F-8DC9-4671-895A-8D2C4B6BE9C7 Q37280942-09E865CC-E327-4D29-8DE3-3B97E5684C02 Q46104100-4AD54DE5-92B5-4120-A413-750A032409C2

P2860

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

Item

http://www.wikidata.org/entity/Q53990815

description

1999 nî lūn-bûn

@nan

1999年の論文

@ja

1999年学术文章

@wuu

1999年学术文章

@zh-cn

1999年学术文章

@zh-hans

1999年学术文章

@zh-my

1999年学术文章

@zh-sg

1999年學術文章

@yue

1999年學術文章

@zh

1999年學術文章

@zh-hant

name

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

@en

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

@nl

type

Item

label

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

@en

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

@nl

prefLabel

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

@en

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

@nl

P1476

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

@en

P2093

Bygdeman M

http://www.w3.org/2001/XMLSchema#string

Danielsson KG

http://www.w3.org/2001/XMLSchema#string

Kovâcs L

http://www.w3.org/2001/XMLSchema#string

Marions L

http://www.w3.org/2001/XMLSchema#string

Resch BA

http://www.w3.org/2001/XMLSchema#string

Swahn ML

http://www.w3.org/2001/XMLSchema#string

Viski S

http://www.w3.org/2001/XMLSchema#string

P2860

Blastocyst implantation depends on maternal expression of leukaemia inhibitory factor

Timing of sexual intercourse in relation to ovulation. Effects on the probability of conception, survival of the pregnancy, and sex of the baby

Onapristone (ZK 98.299): a potential antiprogestin for endometrial contraception.

Comparison of Yuzpe regimen, danazol, and mifepristone (RU486) in oral postcoital contraception.

Mifepristone (RU 486) compared with high-dose estrogen and progestogen for emergency postcoital contraception.

Disruption of follicular maturation and delay of ovulation after administration of the antiprogesterone RU486.

Effects of the antiprogesterone RU 486 in normal women. II. Administration in the late follicular phase.

The effect of antiprogestin on integrin expression in human endometrium: an immunohistochemical study.

Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle.

Delayed endometrial maturation induced by daily administration of the antiprogestin RU 486: a potential new contraceptive strategy.

P304

2788-2790

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/HUMREP/14.11.2788

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

1999-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

12751508

http://www.w3.org/2001/XMLSchema#string

P698

10548623

http://www.w3.org/2001/XMLSchema#string

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

about

P2860

P2860

Contraceptive efficacy of daily administration of 0.5 mg mifepristone.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P5875

P698